Adenosine A2A agonists in development for the treatment of inflammation - Wikidata - thesis-toulmin - TriplyDB

Adenosine A2A agonists in development for the treatment of inflammation

Adenosine A2A agonists in development for the treatment of inflammation

http://www.wikidata.org/entity/Q28261970

about

Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions A2A receptors in inflammation and injury: lessons learned from transgenic animals Adenosine receptors and asthma.Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?Emerging adenosine receptor agonists Thymoquinone, the main constituent of Nigella sativa, affects adenosine receptors in asthmatic guinea pigs The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.Targeting of adenosine receptors in ischemia-reperfusion injury.Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.Activation of adenosine 2A receptors preserves structure and function of podocytes Adenosine and the auditory system.The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.Discovery of New Human A(2A) Adenosine Receptor Agonists: Design, Synthesis, and Binding Mode of Truncated 2-Hexynyl-4'-thioadenosine.The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway.The plant hormone zeatin riboside inhibits T lymphocyte activity via adenosine A2A receptor activation.Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors.The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway Emerging drugs for psoriasis.Neoceptors: reengineering GPCRs to recognize tailored ligands Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease.Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases.A2A adenosine receptor deficiency leads to impaired tracheal relaxation via NADPH oxidase pathway in allergic mice G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development.Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape.History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents.The Effect of Adenosine A2A and A2B Antagonists on Tracheal Responsiveness, Serum Levels of Cytokines and Lung Inflammation in Guinea Pig Model of Asthma.Adenosine A(2A) Receptor and IL-10 in Peripheral Blood Mononuclear Cells of Patients with Mild Cognitive Impairment.Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice.LASSBio-897 Reduces Lung Injury Induced by Silica Particles in Mice: Potential Interaction with the A2A Receptor.Combined treatment with hyaluronan inhibitor Pep-1 and a selective adenosine A2 receptor agonist reduces inflammation in experimental arthritis.

P2860

Q24644038-7949C65F-FD33-49DE-A900-083799E4C0D4 Q24652486-E0B2F781-1166-4E42-B652-CA876DA4EFAD Q24653697-57EFF0EA-79BB-4A75-B5A1-97A76014DC04 Q24676705-D00C8AC5-F434-423D-8FA8-3E41E5B595BA Q27022674-F0A32895-D12F-4BC9-9ECC-B9C68DD2C234 Q28249111-90190C45-DFCA-443E-8FB8-76C206CC3757 Q28391303-3730688E-F783-4ED6-BDA1-F0031898316C Q30409961-46323393-4D3E-416D-AE1C-9A64134E15BA Q30412759-8C2C4212-7997-416D-8018-BEBD8411B1C3 Q30423298-ED70B65F-6E95-47B6-84EC-4E8DE9EECEBC Q30429069-2EBD0EFC-196D-4DB4-846D-B6522F2B239D Q30432457-1BA5F2CA-6697-434D-9291-BDE85F661818 Q30435620-E4B035D7-D29B-4923-909E-28A045CE1937 Q30440525-EDFD4193-DDEF-4906-BE0A-A50A0B03700A Q30440549-F78C4E24-6906-4128-B0A8-0916E23500CB Q30482911-0F28301C-EAC8-480F-B443-D0EDAD086CC3 Q31132502-6422ABB7-D1B4-45FC-973D-341125A434C7 Q33615249-F94B517E-3970-4527-B486-79E19CB0D5B1 Q33971113-EB3F7EFA-EF90-488C-A950-F3CBA9737FE4 Q34536571-FE8A53B8-6CE4-4CEB-8183-882825E36980 Q35249092-EF0113FE-D7C7-4DE7-9C05-E02042538C73 Q36301576-2AE9CD94-E9D4-4EA8-AC6B-26D239A8914E Q36302834-CF6FFE43-0B76-41FD-BA1B-140D5B9C6768 Q36362887-F5813666-B3D1-400A-8173-79EB7405B046 Q36363512-E915D747-D343-4E4B-A41D-2A959E3F141F Q36634244-43853559-992A-4B61-837B-9D18987E73A4 Q36728991-D2512BC7-D4A5-4658-AE56-93C8D1587913 Q36907484-4872F3CC-CD87-4426-9156-71BDDD58E257 Q37006166-4C7D0E8B-E172-4EC1-96E7-26ECD645204C Q37237094-82419BB2-E652-4E62-8499-B6A5BD15BB43 Q37293340-1AC54B7E-836C-40F9-92D3-AE2777AF71B2 Q37710715-B0EC162A-B984-4CC9-8827-E55C03F9626B Q38058320-146C594D-0C66-4DBB-BC45-AAE2CC94A4E8 Q38395423-13FCEF67-EAAE-42CF-B89C-A1EC4A077838 Q41921588-C469F007-33D8-4DC2-A18D-04D781089B59 Q42738860-7138C707-452F-4F92-8330-81C82E043B35 Q43944774-65A0918E-9391-4C0E-A63A-3CD638B43560 Q44927020-85E9C23E-117B-4B17-B649-325717DD6F14 Q45757386-B2452A60-B582-435F-8262-148865C8EDA6 Q46359872-0E58D9B7-2F8C-4E55-9E37-C335B8BA9FB8

P2860

Adenosine A2A agonists in development for the treatment of inflammation

http://www.wikidata.org/entity/Q28261970

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Adenosine A2A agonists in development for the treatment of inflammation

@ast

Adenosine A2A agonists in development for the treatment of inflammation

@en

Adenosine A2A agonists in development for the treatment of inflammation

@nl

type

label

Adenosine A2A agonists in development for the treatment of inflammation

@ast

Adenosine A2A agonists in development for the treatment of inflammation

@en

Adenosine A2A agonists in development for the treatment of inflammation

@nl

prefLabel

Adenosine A2A agonists in development for the treatment of inflammation

@ast

Adenosine A2A agonists in development for the treatment of inflammation

@en

Adenosine A2A agonists in development for the treatment of inflammation

@nl

P1433

Q28261970-29C99527-A466-4727-8BC1-79A60CC166E7

P1476

Q28261970-D6F4968A-16C0-4EDC-956B-6872A2999AE4

P2093

Q28261970-8A74C811-51DF-4F01-8260-91271EAEE596

Q28261970-D56474C7-B925-442E-AA0E-B8D9FE815BFE

Q28261970-DE4C4148-A54A-4C29-B253-5CE2DA52E7BF

P2860

Q28261970-A166B12F-9A9C-450D-A33F-79CB0DB3EC4A

Q28261970-A224A9F8-CF9A-438D-BA84-4D6189972C68

Q28261970-AACCADEC-E74C-4284-83E9-D69B69D62E0A

Q28261970-B5AFDFBC-2B61-4565-B5CA-192B71033FAF

Q28261970-B8CBBFD4-2981-40D4-8675-DD8846CF079B

Q28261970-CB34F8F0-7D8F-4A3C-A27A-6F5DB1C1AB84

Q28261970-FB8FBF1C-A44A-43EC-A3F8-667B5F57A3B9

P304

Q28261970-A4DF19D3-6DA4-406E-9B54-F26BB404506A

P31

Q28261970-6909314C-2BFD-44AF-88A8-220634FF4DE5

P356

Q28261970-4F02764F-D3A8-4B5F-B37A-6081C0F5CD14

P407

Q28261970-70D4FC5D-07A0-4E4B-832F-8081E928B9DD

P433

Q28261970-B6234003-EB51-4E3D-85A5-80C65C6C84FC

P478

Q28261970-67ECEA41-796A-4821-9097-6A99F3D9065B

P577

Q28261970-85EB12CF-046E-4F4F-9A21-31A234ED6A5E

P698

Q28261970-88258C66-9EE1-4240-BDE8-A8FD18352083

P921

Q28261970-1D022798-9BB7-4B37-BD62-DD798B593558

P356

13543784.14.7.797

P1433

Expert Opinion on Investigational Drugs

P1476

Adenosine A2A agonists in development for the treatment of inflammation

@en

P2093

Courtney M Lappas

http://www.w3.org/2001/XMLSchema#string

Gail W Sullivan

http://www.w3.org/2001/XMLSchema#string

Joel Linden

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements

Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways

The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

P304

797-806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.14.7.797

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16022569

http://www.w3.org/2001/XMLSchema#string

P921